The phytocannabinoid, Δ9‐tetrahydrocannabivarin, can act through 5‐HT1A receptors to produce antipsychotic effects
British Journal of Pharmacology2014Vol. 172(5), pp. 1305–1318
Citations Over TimeTop 10% of 2014 papers
Abstract
Our findings suggest that THCV can enhance 5-HT₁A receptor activation, and that some of its apparent antipsychotic effects may depend on this enhancement. We conclude that THCV has therapeutic potential for ameliorating some of the negative, cognitive and positive symptoms of schizophrenia.
Related Papers
- → Synthesis and Characterization of Photolabile Derivatives of Serotonin for Chemical Kinetic Investigations of the Serotonin 5-HT3 Receptor(2000)58 cited
- → Characterization of 5‐HT1A,B and 5‐HT2A,C Serotonin Receptor Binding(2001)5 cited
- → 5-HT<sub>2A</sub>, 5-HT<sub>1B/D</sub>, 5HT<sub>3</sub> and 5-HT<sub>7</sub> receptors as mediators of serotonin-induced direct contractile response of bovine airway smooth muscle(2021)3 cited
- → Evidence for serotonin (5HT) binding sites on murine lymphocytes(1987)21 cited
- → Serotonin (5-HT)-induced enhancement in the colonic motility is mediated through 5-HT1-like and 5-HT2 receptors in dogs(1995)